Product Images Duloxetine

This is a medication called Ascend containing duloxetine hydrochloride. Each capsule contains 33.7mg of the drug which is equivalent to 30mg of duloxetine. The label size is 42 x 28mm (LXH) with a UV varnish on a blank area. The capsules are delayed-release and should be stored at 25°C (77°F) with excursions allowed between 15-30°C (69-86°F). Do not use if the inner seal is broken. The medication guide should be dispensed to each patient by a pharmacist. The medication is manufactured by Akem LaboratoriesL1d, Mumbai, India and distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054.*

This is a medication called "Duloxetine" manufactured by Akem Laboratories in Mumbai, India. Each capsule contains 67.3 mg of duloxetine hydrochloride equivalent to 60 mg of duloxetine. The product code is NDC 67877-265-30. The label dimensions are 40 x 28 mm (LXH) and should have UV varnish. The medication should be stored at 25°C (77°F) with excursions permitted at 15-30°C (69-86°F). The label warns not to use if the inner seal is missing or broken. It comes in a bottle of 30 capsules distributed by Ascend Laboratories in Parsippany, NJ.*

This appears to be a chart displaying the percentage of patients who experienced improvement in pain from their baseline after receiving either a placebo or a certain medication. The medication name appears to be "Didoreine" and the dosage is listed as "601120 g once sy". The chart shows varying levels of improvement, with a range from 0% to 100%.*

The text is showing a chart or graph displaying the percentage of patients who have improved based on a measure of pain compared to a baseline (BOCF). The graph displays measurements denoted by MO, with values ranging from 0 to 230, and S0, with a value of 60. There is an axis for percent improvement ranging from 0 to 100.*

This appears to be a graph showing the time from randomization to relapse in a certain group of patients. The x-axis represents the number of days and the y-axis represents the proportion of patients who have relapsed during that time period. However, without additional context, it is difficult to provide a more specific description of the data.*